LINCO-SPECTIN SOLUTION INJECTABLE POUR BOVINS (VEAUX) OVINS CAPRINS PORCINS VOLAILLES CHATS ET CHIENS
LINCO-SPECTIN SOLUTION INJECTABLE POUR BOVINS (VEAUX) OVINS CAPRINS PORCINS VOLAILLES CHATS ET CHIENS
Authorised
- Lincomycin hydrochloride monohydrate
- Spectinomycin sulfate tetrahydrate
Product identification
Medicine name:
LINCO-SPECTIN SOLUTION INJECTABLE POUR BOVINS (VEAUX) OVINS CAPRINS PORCINS VOLAILLES CHATS ET CHIENS
Active substance:
- Lincomycin hydrochloride monohydrate
- Spectinomycin sulfate tetrahydrate
Target species:
-
Cattle (calf)
-
Pig
-
Cat
-
Sheep
-
Goat
-
Dog
-
Poultry
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Lincomycin hydrochloride monohydrate56.70milligram(s)1.00millilitre(s)
-
Spectinomycin sulfate tetrahydrate151.17milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle (calf)
-
Meat and offal14day
-
-
Pig
-
Meat and offal14day
-
-
Cat
-
Sheep
-
Meat and offal14day
-
Milkno withdrawal periodEn l'absence de détermination d'un temps d'attente pour le lait, ne pas utiliser chez les femelles productrices de lait de consommation, en lactation ou en période de tarissement ni chez les futures productrices de lait de consommation dans les 2 mois précédant la mise-bas.
-
-
Goat
-
Meat and offal14day
-
-
Dog
-
-
Subcutaneous use
-
Poultry
-
Meat and offal14day
-
Eggsno withdrawal periodEn l'absence de LMR pour les œufs, ne pas utiliser chez les espèces pondeuses productrices d'œufs de consommation
-
-
Goat
-
Milkno withdrawal periodEn l'absence de détermination d'un temps d'attente pour le lait, ne pas utiliser chez les femelles productrices de lait de consommation, en lactation ou en période de tarissement ni chez les futures productrices de lait de consommation dans les 2 mois précédant la mise-bas.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
- Bela-Pharm GmbH & Co. KG
- Zoetis Belgium
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/7501878 8/1992
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 27/03/2025
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 24/03/2025
How useful was this page?: